x

ENZON PHARMACEUTICALS, INC. (OTC:ENZN)

Health Care/Life Sciences • Pharmaceuticals
CIK 727510
Company

Enzon Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the provision of licensing arrangements related to sales of drug products that utilize its proprietary technology. The company was founded on September 17, 1981 and is headquartered in Cranford, NJ.

Address
20 Commerce Drive
Suite 135
Cranford, New Jersey 07016
Employees
None
Stock Info
Close
$0.1155
Day Range
0.1078 - 0.1138
52 Week Range
0.0600 - 0.2400
Average volume
110.43K
Short Interest
N/A (N/A)
% of Float Shorted
N/A
Market Cap
$8.02M
Revenue
N/A
Net Income
$1.37M
2020 Sales Growth
N/A
Rev. per Employee
N/A
P/E Ratio
N/A
EPS
-$0.0067
Yield
N/A
Dividend
N/A
Ex-Dividend Date
N/A
Key Executives
Board Of Directors
Director
Stephen T. Wills
Chairman
Randolph C. Read
Independent Director
Jordan Bleznick
Independent Director
Jaffrey Adam Firestone
SEC filings
DateFormEvent
19 Dec, 2024 SCHEDULE 1
5 Nov, 2024 10-Q
1 Oct, 2024 8-K
19 Aug, 2024 SC 13D/A
8 Aug, 2024 DEF 14A
8 Aug, 2024 10-Q
8 Aug, 2024 DEFA14A
8 Aug, 2024 ARS
29 Jul, 2024 PRE 14A
11 Jul, 2024 8-K/A
2 Jul, 2024 8-K
14 Jun, 2024 8-K
22 May, 2024 8-K
22 May, 2024 8-A12G/A
10 May, 2024 10-Q
26 Apr, 2024 10-K/A
20 Mar, 2024 10-K
5 Jan, 2024 8-K
9 Nov, 2023 10-Q
7 Aug, 2023 10-Q
16 Jun, 2023 4
14 Jun, 2023 8-K
5 May, 2023 10-Q
20 Apr, 2023 DEFA14A
20 Apr, 2023 DEF 14A
20 Apr, 2023 ARS
16 Feb, 2023 10-K
6 Jan, 2023 8-K
9 Nov, 2022 10-Q
4 Aug, 2022 10-Q
21 Jun, 2022 3
15 Jun, 2022 8-K
26 Apr, 2022 10-Q
22 Apr, 2022 DEF 14A
22 Apr, 2022 DEFA14A
25 Feb, 2022 10-K
5 Nov, 2021 10-Q
17 Aug, 2021 4
5 Aug, 2021 10-Q
8 Jun, 2021 8-K
8 Jun, 2021 8-A12G/A
4 May, 2021 10-Q
14 Apr, 2021 DEF 14A
14 Apr, 2021 DEFA14A
2 Apr, 2021 PRE 14A
23 Feb, 2021 10-K
4 Jan, 2021 8-K CEO Change
Last update:2025-03-06 13:34:22.593041
ENZON PHARMACEUTICALS, INC. by TradingView

Sign Up to Subscribe